← back to search

Wei Bian

Harbin Medical University · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include MicroRNA in disease regulation, Cancer-related molecular mechanisms research, Extracellular vesicles in disease, and RNA modifications and cancer.
h-index
17
citations
1,158
works
47
NIH funding
primary concept
email

Recent publications

Hypoxia-conditioned BMSC exosomes improve short-term spinal cord injury outcomes via the miR-615-3p/PDE4C-mediated cAMP/PKA pathway
Stem Cell Research & Therapy 2026cited by 2position: firstdoi
Lipid Visualization of 3D-hetero-type Multicellular Spheroids During the Spatiotemporal Progression of Pancreatic Cancer
Journal of Analysis and Testing 2025cited by 4position: middledoi
[Retracted] miR‑381 functions as a tumor suppressor by targeting ETS1 in pancreatic cancer
International Journal of Molecular Medicine 2025cited by 0position: lastdoi
Exosomes From Muscle‐Derived Stem Cells Repair Peripheral Nerve Injury by Inhibiting Ferroptosis via the Keap1‐Nrf2‐Ho‐1 Axis
Journal of Cellular Biochemistry 2024cited by 5position: middledoi
Muscle-derived stem cell exosomes with overexpressed miR-214 promote the regeneration and repair of rat sciatic nerve after crush injury to activate the JAK2/STAT3 pathway by targeting PTEN
Frontiers in Molecular Neuroscience 2023cited by 24position: middledoi
Oncogenic lncRNA ZNFX1 antisense RNA 1 promotes osteosarcoma cells proliferation and metastasis by stabilizing serine and arginine‑rich splicing factor 3
Bioengineered 2022cited by 19position: middledoi
<scp>miR</scp> ‐493 by regulating of <scp>c‐Jun</scp> targets Wnt5a/ <scp>PD‐L1</scp> ‐inducing esophageal cancer cell development
Thoracic Cancer 2021cited by 16position: firstdoi
The effect of gemcitabine combined with AMD3100 applying to cholangiocarcinoma RBE cell lines to CXCR4/CXCL12 axis
Scandinavian Journal of Gastroenterology 2021cited by 2position: lastdoi
Exosomal lncRNA ZFAS1 regulates esophageal squamous cell carcinoma cell proliferation, invasion, migration and apoptosis via microRNA-124/STAT3 axis
Journal of Experimental & Clinical Cancer Research 2019cited by 204position: middledoi
miR‑381 functions as a tumor suppressor by targeting ETS1 in pancreatic cancer
International Journal of Molecular Medicine 2019cited by 26position: lastdoi
miR-493 by regulating of c-Jun targets Wnt5a/PD-L1-inducing esophageal cancer cell development
Research Square 2019cited by 0position: firstdoi
Potential Role of microRNA-183 as a Tumor Suppressor in Hepatocellular Carcinoma
Cellular Physiology and Biochemistry 2018cited by 11position: firstdoi
Necrosis of osteosarcoma cells induces the production and release of high‑mobility group box 1 protein
Experimental and Therapeutic Medicine 2017cited by 8position: middledoi
Effect of norcantharidin on human cholangiocarcinoma cells line RBE: histochemical and electron microscopic study
Zhonghua shiyan waike zazhi 2015cited by 0position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Xiangyu Zeng · Harbin Medical University4 papers (2022–2026)Jianyu Liu · University of Kentucky3 papers (2022–2024)Zewei Gao · Jiangsu University3 papers (2023–2026)Yishuai Li · Qingdao University3 papers (2019–2021)Mingyan Guan · Harbin Medical University3 papers (2022–2026)Guanyi He · Harbin Medical University2 papers (2022–2023)Bu Tegeleqi · Harbin Medical University2 papers (2023–2024)Chuan Wang · Hebei Medical University2 papers (2019–2021)Guanen Qiao · Soochow University2 papers (2019–2025)Haoze Li · Harbin Medical University2 papers (2024–2026)Ren Niu · Hebei Medical University2 papers (2019–2021)Jun Wang · 458th Hospital PLA2 papers (2019–2025)Ziwen Liu · Harbin Medical University2 papers (2024–2026)Haiyong Zhu · Hebei Medical University2 papers (2019–2021)Xuebo Qin · Hospital of Hebei Province2 papers (2019–2021)Shaolin Gao · Hebei Medical University2 papers (2019–2021) · 1 papers (2015–2015)Baoen Shan · Hebei Medical University1 papers (2019–2019)Wenbo Xu · Ministry of Education1 papers (2022–2022)Sanguang Liu · Hebei Medical University1 papers (2021–2021)